Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 6Thoracic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 33Pain, Postoperative 4Chronic Pain 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Breast Diseases 2Brain Neoplasms 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Skin Diseases 1Seroma 1Recurrence 1Radiation Injuries 1Postoperative Hemorrhage 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Hot Flashes 1Hodgkin Disease 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1

Interventions

pembrolizumab 44Cyclophosphamide 21Nivolumab 18fludarabine 10durvalumab 8Paclitaxel 8Magnetic Resonance Spectroscopy 8Interleukin-2 8Docetaxel 8aldesleukin 7Radiosurgery 7Ipilimumab 7spartalizumab 6poly ICLC 6fludarabine phosphate 6atezolizumab 6Specimen Handling 6Radiotherapy 6Carboplatin 6cemiplimab 5Drug Therapy 5Cisplatin 5Biopsy 5Temozolomide 4Immune Checkpoint Inhibitors 4tremelimumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3pazopanib 3avelumab 3Trastuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Sodium Chloride × Breast × Clear all
NCT04899908 2026-03-19

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Brigham and Women's Hospital

Phase 2 Active not recruiting
134 enrolled
BreastCNSDermatologicGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡